Summary

Premium Phosphosite-Specific 7TM Antibodies serve as a crucial resource for GPCR researchers, offering precise and sensitive tools for studying cellular signaling pathways. These antibodies are engineered for high sensitivity and specificity, making them ideal for detecting specific protein interactions and functional activity at the cellular level. With a diverse panel covering GPCRs, adenosine receptors, and various kinases, researchers can utilize these reagents to comprehensively map complex signaling networks. The 7TM products enable researchers to perform detailed immunohistochemistry and phospho-IHC protocols on biological samples for clinical and biomedical applications.

Select your country of delivery to ensure convenient shipment and support access, which simplifies the logistics and technical requirements associated with using these antibodies. The extensive receptor nomenclature database allows scientists to quickly reference correct protein names while navigating the vast number of GPCR families and receptor variants available. Payment information is clearly listed to facilitate secure order placement across various financial methods. Customer support is readily accessible for inquiries regarding ordering procedures or addressing technical needs. Shipping costs are included, and reliable delivery is assured for international orders. Contact Us to Order remains a primary contact point for resolving any concerns before placing a final purchase. This comprehensive suite provides the necessary infrastructure for efficient and high-impact GPCR research.

Title

Phosphosite-Specific GPCR Antibodies | 7TM Antibodies®

Description

Premium phosphorylation state--specific antibodies for your GPCR research ✅ Highly cited ✔ NOT available elsewhere! NEW PRODUCTS

Keywords

receptors, receptor, antibodies, information, support, shipping, costs, payment, contact, order, customer, nomenclature, assays, menu, acid, protocol, delivery

NS Lookup

A 178.250.9.111

Dates

Created 2026-04-13

Updated 2026-04-13

Summarized 2026-04-14